GB9417742D0 - Macrophage stimulating composition - Google Patents
Macrophage stimulating compositionInfo
- Publication number
- GB9417742D0 GB9417742D0 GB9417742A GB9417742A GB9417742D0 GB 9417742 D0 GB9417742 D0 GB 9417742D0 GB 9417742 A GB9417742 A GB 9417742A GB 9417742 A GB9417742 A GB 9417742A GB 9417742 D0 GB9417742 D0 GB 9417742D0
- Authority
- GB
- United Kingdom
- Prior art keywords
- macrophage stimulating
- stimulating composition
- composition
- macrophage
- stimulating
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Priority Applications (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB9417742A GB9417742D0 (en) | 1994-09-03 | 1994-09-03 | Macrophage stimulating composition |
PCT/GB1995/002077 WO1996007420A1 (en) | 1994-09-03 | 1995-09-04 | Macrophage stimulating composition comprising a non-ionic surfactant |
AU33940/95A AU3394095A (en) | 1994-09-03 | 1995-09-04 | Macrophage stimulating composition comprising a non-ionic surfactant |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB9417742A GB9417742D0 (en) | 1994-09-03 | 1994-09-03 | Macrophage stimulating composition |
Publications (1)
Publication Number | Publication Date |
---|---|
GB9417742D0 true GB9417742D0 (en) | 1994-10-19 |
Family
ID=10760787
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GB9417742A Pending GB9417742D0 (en) | 1994-09-03 | 1994-09-03 | Macrophage stimulating composition |
Country Status (3)
Country | Link |
---|---|
AU (1) | AU3394095A (en) |
GB (1) | GB9417742D0 (en) |
WO (1) | WO1996007420A1 (en) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2009534464A (en) * | 2006-04-24 | 2009-09-24 | ブルース メディカル アクテボラゲット | Polymeric anticancer agent |
ES2370205B2 (en) * | 2010-05-18 | 2012-07-04 | Universidad De Santiago De Compostela | USE OF POLOXAMINS AS INDUCERS OF THE OSTEOGENIC DIFFERENTIATION OF MESENQUIMAL CELLS |
CN114259463B (en) * | 2022-02-11 | 2023-03-28 | 山东大学 | PF-HA-diSE hydrogel with anti-inflammatory effect of targeted complement protein and preparation method and application thereof |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2520619A1 (en) * | 1982-01-29 | 1983-08-05 | Bocquet Roger | REVERTING COMPOSITION BASED ON THE POLYETHYLENE GLYCOL-DIMETHYLSULFOXIDE-THEOPHYLLINE ASSOCIATION AND ITS USE IN CANCEROLOGY |
EP0154316B1 (en) * | 1984-03-06 | 1989-09-13 | Takeda Chemical Industries, Ltd. | Chemically modified lymphokine and production thereof |
ZA881694B (en) * | 1987-03-17 | 1988-09-06 | Akzo N.V. | Adjuvant mixture |
WO1990005534A1 (en) * | 1988-11-23 | 1990-05-31 | Genentech, Inc. | Polypeptide derivatives |
US4902502A (en) * | 1989-01-23 | 1990-02-20 | Cetus Corporation | Preparation of a polymer/interleukin-2 conjugate |
US5470568A (en) * | 1992-02-13 | 1995-11-28 | Arch Development Corporation | Methods and compositions of a polymer (poloxamer) for cell repair |
AU691225B2 (en) * | 1993-11-10 | 1998-05-14 | Schering Corporation | Improved interferon polymer conjugates |
-
1994
- 1994-09-03 GB GB9417742A patent/GB9417742D0/en active Pending
-
1995
- 1995-09-04 AU AU33940/95A patent/AU3394095A/en not_active Abandoned
- 1995-09-04 WO PCT/GB1995/002077 patent/WO1996007420A1/en active Application Filing
Also Published As
Publication number | Publication date |
---|---|
AU3394095A (en) | 1996-03-27 |
WO1996007420A1 (en) | 1996-03-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ZA951012B (en) | Composition | |
ZA9510554B (en) | Substituted 1H-imidazoles | |
ZA95776B (en) | Novel formulation | |
EP0778836A4 (en) | Substituted 9-alkyladenines | |
ZA9533B (en) | Pentolifylline therapy | |
EP0768089A4 (en) | Health composition | |
EP0739623A4 (en) | Dermatologic composition | |
HU9502378D0 (en) | Substituted biphenyl-oxazolinones | |
GB9415810D0 (en) | Composition | |
GB9417742D0 (en) | Macrophage stimulating composition | |
GB9410139D0 (en) | Hebicidal composition | |
EP0797592A4 (en) | Human stanniocalcin-alpha | |
GB2290117B (en) | Improvements relating to airlocks | |
ZA947865B (en) | Human glactokinase | |
GB9404989D0 (en) | Lipomimetric formulation | |
EP0795006A4 (en) | HUMAN MutT2 | |
GB9405243D0 (en) | Aegis | |
GB9420354D0 (en) | Composition | |
GB9417808D0 (en) | Composition | |
GB9408548D0 (en) | Composition | |
HU9401077D0 (en) | David-star composition | |
GB9412943D0 (en) | Composition | |
GB9405023D0 (en) | Composition | |
GB9407734D0 (en) | Composition | |
PL304514A1 (en) | Resin-asphalt composition |